03/02/2010 07:00
Syntopix announces a Directorate change with Tom Bannatyne joining as Chairman.
12/11/2009 07:00
Syntopix announces positive results for its lead dermatological compound SYN0126
12/11/2009 07:00
Syntopix focuses development efforts around three specific core compounds
14/04/2009 13:13
EXCLUSIVE EVALUATION AGREEMENT
Syntopix signs an exclusive evaluation agreement with a major consumer healthcare company..